These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6758934)

  • 21. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications for antiarrhythmic therapy as prophylaxis against sudden death.
    Peter T; Hamamoto H; Jordon J; Platt M; Mandel W
    Cardiovasc Clin; 1980; 11(1):249-66. PubMed ID: 7002303
    [No Abstract]   [Full Text] [Related]  

  • 24. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventricular premature beats.
    Kastor JA
    Adv Intern Med; 1983; 28():63-91. PubMed ID: 6340432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rhythm troubles: when and how to treat them?].
    Jaeger M
    Schweiz Med Wochenschr; 1981 Nov; 111(45):1691-3. PubMed ID: 7313634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Repetitive ventricular response by programmed electrostimulation of the heart: frequency and clinical significance].
    Meinertz T; Treese N; Kasper W; Pop T
    Herz; 1984 Feb; 9(1):34-44. PubMed ID: 6706284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
    Zoni Berisso M; Carratino L; De Caro E; Ferroni A; Vecchio C
    G Ital Cardiol; 1987 Mar; 17(3):233-8. PubMed ID: 3301504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of ventricular ectopic activity during 24-hour monitoring and exercise testing in patients with coronary heart disease.
    Ryan M; Lown B; Horn H
    N Engl J Med; 1975 Jan; 292(5):224-9. PubMed ID: 1110691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone and post-MI patients.
    Nademanee K; Singh BN; Stevenson WG; Weiss JN
    Circulation; 1993 Aug; 88(2):764-74. PubMed ID: 7687937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of antiarrhythmic drug efficacy in the treatment of ventricular arrhythmias.
    Morganroth J
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):669-73. PubMed ID: 2076377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newer antiarrhythmic agents for patients with coronary artery disease.
    Schroeder JS
    Angiology; 1978 Jan; 29(1):22-32. PubMed ID: 343649
    [No Abstract]   [Full Text] [Related]  

  • 38. Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.
    Pratt CM; Théroux P; Slymen D; Riordan-Bennett A; Morisette D; Galloway A; Seals AA; Hallstrom A
    Am J Cardiol; 1987 Feb; 59(4):278-83. PubMed ID: 2880497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymptomatic ventricular ectopy. To treat or not to treat?
    Lofgren RP; Hoppe RB
    Postgrad Med; 1983 Apr; 73(4):261-4, 267-71, 274. PubMed ID: 6132372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute myocardial ischemia and ventricular arrhythmias in the pathogenesis of sudden cardiac death in coronary disease].
    Zehender M; Faber T; Brunner M; Grom A
    Z Kardiol; 2000; 89 Suppl 3():13-23. PubMed ID: 10810781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.